CALADRIUS BIOSCIENCES, INC. Stock Agreements

11 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Series D Preferred Stock Purchase Agreement, dated April 26, 2022, among Caladrius Biosciences, Inc. and Cend Therapeutics Inc
Stock Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
2022
Description of Capital Stock of Caladrius Biosciences, Inc.
Stock Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
2021
Description of Capital Stock of Caladrius Biosciences, Inc.
Stock Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
2020
Common Stock Purchase Agreement between Caladrius Biosciences, Inc. and Aspire Capital Fund, LLC
Purchase Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
NY
2015
Common Stock Purchase Agreement between NeoStem, Inc. and Aspire Capital Fund, LLC (May 4, 2015)
Purchase Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
NY
2015
Common Stock Purchase Agreement between NeoStem, Inc. and Aspire Capital Fund, LLC (September 28, 2011)
Purchase Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
NY
2011
Stock Purchase and Assignment Agreement among Becton, Dickinson and Company, Progenitor Cell Therapy, LLC, and Athelos Corporation
Purchase Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
NJ
2011
Warrant Agreement to Purchase Common Stock of NeoStem, Inc. under Regulation D
Warrant Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
2009
Certificate of Designation for Series D Convertible Redeemable Preferred Stock of NeoStem, Inc.
Articles of Amendment
CALADRIUS BIOSCIENCES, INC.
Biotechnology
2009
Common Stock Purchase Agreement between NeoStem, Inc. and Aspire Capital Fund, LLC (March 10, 2014)
Purchase Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
NY
2014
Amendment to Common Stock Purchase Agreement between NeoStem, Inc. and Aspire Capital Fund, LLC
Modification Agreements
CALADRIUS BIOSCIENCES, INC.
Biotechnology
2012